Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3827 ARTÍCULOS , VIENDO DEL 976 AL 990

Association between the BDNF G196A and C270T polymorphisms and Parkinson's disease: a meta-analysis

Dai L, Wang D, Meng H, Zhang K, Fu L, Wu Y, Bai Y.

Int J Neurosci. 2013 Oct;123(10):675-83. doi: 10.3109/00207454.2013.798784. Epub 2013 Jun 20.

Correlation of inner retinal thickness evaluated by spectral-domain optical coherence tomography and contrast sensitivity in Parkinson disease

Adam CR, Shrier E, Ding Y, Glazman S, Bodis-Wollner I.

J Neuroophthalmol. 2013 Jun;33(2):137-42. doi: 10.1097/WNO.0b013e31828c4e1a.

[Molecular markers of endothelial damage in patients with Parkinson's disease]

Makarov NS, Spiridonova SV, Nikitina VV, Voskresenskaia ON, Zakharova NB.

Zh Nevrol Psikhiatr Im S S Korsakova. 2013;113(3):61-4.

Ambient particulate matter and its potential neurological consequences

Loane C, Pilinis C, Lekkas TD, Politis M.

Rev Neurosci. 2013;24(3):323-35. doi: 10.1515/revneuro-2013-0001.

Sleep disorders in Parkinson's disease: a narrative review of the literature

Raggi A, Bella R, Pennisi G, Neri W, Ferri R.

Rev Neurosci. 2013;24(3):279-91. doi: 10.1515/revneuro-2013-0002.

MediGuide in supraventricular tachycardia: initial experience from a multicentre registry

Sommer P, Piorkowski C, Gaspar T, Eitel C, Derndorfer M, Martinek M, Pürerfellner H, Arya A, Hindricks G, Rolf S.

Europace. 2013 Sep;15(9):1292-7. doi: 10.1093/europace/eut090. Epub 2013 Apr 23.

Genetic variation in the human brain dopamine system influences motor learning and its modulation by L-Dopa

Pearson-Fuhrhop KM, Minton B, Acevedo D, Shahbaba B, Cramer SC.

PLoS One. 2013 Apr 17;8(4):e61197. doi: 10.1371/journal.pone.0061197. Print 2013.

Olfactory training in patients with Parkinson's disease

Haehner A, Tosch C, Wolz M, Klingelhoefer L, Fauser M, Storch A, Reichmann H, Hummel T.

PLoS One. 2013 Apr 17;8(4):e61680. doi: 10.1371/journal.pone.0061680. Print 2013.

N-(6-[(18)F]Fluoro-4-phenoxypyridin-3-yl)-N-(2-methoxybenzyl)acetamide

Chopra A.

2013 Mar 26 [updated 2013 Apr 25]. In: Molecular Imaging and Contrast Agent Database (MICAD) [Internet]. Bethesda (MD): National Center for Biotechnology Information (US); 2004–2013.

Transverse-sigmoid sinus dural arteriovenous fistula presenting with parkinsonism

Hattori T, Takeuchi T, Kabeya R, Ando K, Tosaki F.

Neurol Med Chir (Tokyo). 2013;53(4):224-7. doi: 10.2176/nmc.53.224.

"Sleep benefit" in Parkinson's disease: a systematic review

van Gilst MM, Bloem BR, Overeem S.

Parkinsonism Relat Disord. 2013 Jul;19(7):654-9. doi: 10.1016/j.parkreldis.2013.03.014. Epub 2013 Apr 21.

Multicentre analysis of 178,992 type 2 diabetes patients revealed better metabolic control despite higher rates of hypertension, stroke, dementia and repeated inpatient care in patients with comorbid Parkinson's disease

Scheuing N, Best F, Dapp A, Dreyhaupt I, Filz HP, Krakow D, Lang W, Siegel E, Zeyfang A, Holl RW; DPV initiative and the German BMBF Competence Network Diabetes mellitus.

Parkinsonism Relat Disord. 2013 Jul;19(7):687-92. doi: 10.1016/j.parkreldis.2013.03.011. Epub 2013 Apr 21.

Multiple controls exerted by 5-HT2C receptors upon basal ganglia function: from physiology to pathophysiology

De Deurwaerdère P, Lagière M, Bosc M, Navailles S.

Exp Brain Res. 2013 Oct;230(4):477-511. doi: 10.1007/s00221-013-3508-2. Epub 2013 Apr 25.

Alpha-synuclein and intracellular trafficking: impact on the spreading of Parkinson's disease pathology

Eisbach SE, Outeiro TF.

J Mol Med (Berl). 2013 Jun;91(6):693-703. doi: 10.1007/s00109-013-1038-9. Epub 2013 Apr 25.

The coming crisis: obtaining care for the growing burden of neurodegenerative conditions

Dorsey ER, George BP, Leff B, Willis AW.

Neurology. 2013 May 21;80(21):1989-96. doi: 10.1212/WNL.0b013e318293e2ce. Epub 2013 Apr 24.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias